NEWS
View news from our Featured Companies.
ChromaDex Corporation Reports Third Quarter 2022 Financial Results
Total net sales of $17.1 million, with gross margin of 59.8%, lower operating expenses, and a net loss and Adjusted EBITDA loss of only $1.0 million and $1.2 million, respectively, for the three months ended September 30, 2022. LOS ANGELES - ChromaDex Corp....
LiqTech International to Discuss Third Quarter 2022 Results on Thursday, November 10, 2022
Management to Host Conference Call on Thursday, November 10, 2022, at 9:00 a.m. ET BALLERUP, Denmark, Nov. 1, 2022 -- LiqTech International, Inc. (NASDAQ: LIQT), a clean technology company that manufactures and markets highly specialized filtration products and...
Shuttle Pharmaceuticals Appoints Bette Jacobs to its Board of Directors
ROCKVILLE, Md., Nov. 1, 2022 --Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy (RT), today announced the...
INVO Bioscience Highlights INVOcell Progress From the 2022 American Society for Reproductive Medicine (ASRM) Congress & Expo
- The multi-billion-dollar global fertility market is predicted to reach approximately US$47.9 billion by 2030, yet remains severely underserved with many patients (upwards of 90% by many estimates) unable to access affordable treatment. - The INVOcell solution...
Reviva Pharmaceuticals Announces Global Enrollment Update for Pivotal Phase 3 RECOVER Study Evaluating Brilaroxazine for Schizophrenia
- Enrollment ongoing at multiple sites in the US and Europe; site initiation in Asia expected in November 2022 - - Enrollment on pace, with over 30% enrolled in the United States - - Topline data for RECOVER evaluating brilaroxazine for schizophrenia expected in...
Mogo Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
VANCOUVER, British Columbia - Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) ("Mogo" or the "Company"), one of Canada's leading financial technology companies, today announced that on October 28, 2022, it received a written notification (the "Notification Letter") from the Nasdaq...
S&W Increases Australian-Based Banking Facilities to AUD $49 Million
LONGMONT, Colo. , Oct. 27, 2022 -- S&W Seed Company (Nasdaq: SANW), a global agricultural company, today announced the Company has extended and increased its credit facilities with National Australia Bank Limited (NAB) to a combined maximum of AUD $49 million...
IRADIMED CORPORATION to Hold 2022 Third Quarter Financial Results Conference Call on November 3rd
WINTER SPRINGS, Fla., Oct. 27, 2022 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 third quarter financial results before the market opens on Thursday, November 3rd. IRADIMED management will host a conference call the...
ChromaDex to Report Third Quarter Financial Results on Wednesday, November 2, 2022
LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC) ("the Company"), a global bioscience company dedicated to healthy aging, announced that it will hold a conference call on Wednesday, November 2, 2022 at 4:30 p.m. ET to discuss its financial results for the third quarter,...
PolyPid to Report Third Quarter 2022 Financial Results and Operational Highlights on November 9, 2022
PETACH TIKVA, Israel, Oct. 26, 2022 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its third quarter 2022 financial results and operational highlights...
Aytu BioPharma Announces Agreement with Avenue Venture Debt Fund to Extend Interest-Only Period of Company’s Term Loan
Amendment of Secured Loan Agreement Extends Interest-Only Period to January 2024Amendment Defers Over $3 Million in Principal Payments Beyond 2023Note Matures in January 2025, with Additional Extensions of the Interest-Only Period Available, Subject to Achievement of...
S&W Reports Preliminary Financial Results for the First Quarter of Fiscal 2023
S&W to Report First Quarter Fiscal 2023 Financial Results on November 10, 2022 LONGMONT, Colo., Oct. 25, 2022 -- S&W Seed Company (Nasdaq: SANW), a global agricultural company, today announced preliminary financial results for the first quarter of fiscal 2023...
ChromaDex’s Tru Niagen® Won the “Most Popular Brand of the Year Award” at China International Natural Health & Nutrition Expo’s (NHNE) Prestigious Nutrition Planet Awards
Tru Niagen® was recognized for its industry-leading research, increased presence on cross-border e-commerce channels, and high engagement on several social media platforms in Mainland China LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC), a global bioscience company...
INVOcell Review Published in Current Opinion in Obstetrics and Gynecology
SARASOTA, Fla., Oct. 21, 2022 -- INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell ® medical device and the intravaginal culture ("IVC") procedure it enables,...
PolyPid Announces Cost Reduction Plan
Reduction of Approximately 20% in Organization Headcount Company Expects to Extend Cash Runway into Q3 2023 PolyPid Intends to Discuss Regulatory Pathway for D-PLEX100 for Prevention of Surgical Site Infections in Abdominal Surgery with U.S. and EU Regulatory...
INVO Bioscience to Exhibit at the 2022 American Society for Reproductive Medicine (ASRM) Congress & Expo
SARASOTA, Fla. and ANAHEIM, Calif., Oct. 17, 2022 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOcell®, an effective and affordable treatment for...
Kiora Pharmaceuticals Announces Publication of Phase 1 Trial Results for KIO-100 as a Treatment for Ocular Inflammatory Disease
Salt Lake City, Utah--(October 17, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") announced that results from a Phase 1 study of KIO-100 (formerly PP-001) demonstrate its potential as a treatment for non-infectious uveitis, an...
Mogo’s Portfolio Company, Coinsquare, Announces New Status as Canada’s First IIROC-regulated Cryptocurrency Dealer and Marketplace Member
VANCOUVER, Canada - Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) ("Mogo" or the "Company") today announced that Coinsquare, Canada's longest operating crypto asset trading platform and a company in which Mogo is an approximate 34% shareholder, received approval from the...
Aytu BioPharma Announces Strategic Shift to Focus on Commercial Operations and Indefinite Suspension of Clinical Development Programs
Following a corporate review, Aytu BioPharma is indefinitely suspending clinical development and removing expenses related to AR101/enzastaurin, Healight, and NT0502, and focusing on revenue growth and near-term cash flow generationAytu is expecting to generate...
Kiora Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements
Salt Lake City, Utah--(October 13, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") announced today that it has received a Bid Price Compliance Letter from The Nasdaq Stock Market LLC ("Nasdaq") on October 12, 2022 informing Kiora that it...
Aytu BioPharma (AYTU) Fireside Chat
In this presentation, we welcome Aytu BioPharma, NASDAQ ticker symbol of AYTU. And with us today is their Chief Executive Officer, Josh Disbrow. Aytu BioPharma is a pharmaceutical company commercializing a portfolio of commercial prescription therapeutics. This...
Kiora Pharmaceuticals to Implement 1-for-40 Reverse Split
Salt Lake City, Utah--(September 26, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") announced that its stockholders authorized a reverse stock split of the Company's common stock. Following the annual stockholder meeting, the board of...
Reviva Pharmaceuticals to Present at the Lytham Partners Fall 2022 Investor Conference
CUPERTINO, Calif., Sept. 26, 2022 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...
InfuSystem Appoints R. Rimmy Malhotra to the Board of Directors
ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced...
Dr. Sue Ellen Carpenter of INVO Bioscience’s Atlanta-based INVO Center – Bloom Fertility – Named Top Doctor by Castle Connolly
SARASOTA, Fla. and ATLANTA, Sept. 22, 2022 -- INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell ® medical device and the intravaginal culture ("IVC") procedure...